SMOOCH - Small Volume Challenges to Predict Volume Responsiveness: Prospective Interventional Study (SMOOCH)

October 22, 2010 updated by: Technical University of Munich
  • test for volume responsiveness
  • PiCCO-guided infusion over a pre-defined period of time

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Munich, Germany, 81675
        • Recruiting
        • 2nd Medical Department, Klinikum rechts der Isar
        • Contact:
        • Principal Investigator:
          • Wolfgang Huber, MD
        • Sub-Investigator:
          • Josef Hoellthaler, MD
        • Sub-Investigator:
          • Andrea Herrmann

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients are equipped with PiCCO monitoring independently to the study.
  • One criteria of decreased usefulness of the parameters of preload/volume responsiveness available using the PiCCO device:

    1. Femoral access of the central venous catheter precluding application of the normal ranges of global enddiastolic volume index and central venous pressure.
    2. Absence of sinus rhythm and/or controlled ventilation precluding the use of stroke volume variation.
    3. Evidence of increased intraabdominal pressure which is known to further reduce the usefulness of central venous pressure.
    4. Contradictory suggestions by stroke volume variation and global enddiastolic volume index.
    5. Intolerance of passive leg raising.
    6. Absence of therapeutic alternatives to volume resuscitation.

Exclusion Criteria:

  • Extravascular volume-over plus: global enddiastolic volume index > 1000ml/sqm
  • Pulmonary edema: extravascular lungwater index > 20ml/kg
  • Cardiogenic shock without volume deficiency (cardiac index <2L/min; global enddiastolic volume index > 850ml/sqm)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Test of volume responsiveness using crystalloids
Infusion of 7ml/kg crystalloid over 30 minutes, Performing transpulmonary thermodilutions after 0min, 15min and 30min. Recording of pulse contour cardiac index, heart rate and mean arterial pressure after 5, 10, 15, 20, 25 and 30min. Catecholamines are kept stable over the 30min period.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Prediction of volume responsiveness defined as an increase in Cardiac Index of ≥ 15% after transpulmonary thermodilution measurement of 15 minutes
Time Frame: 15 minutes after start of infusion
15 minutes after start of infusion
Prediction of volume responsiveness defined as an increase in Cardiac Index of ≥ 15% after transpulmonary thermodilution measurement of 30 minutes
Time Frame: 30 minutes after start of infusion
30 minutes after start of infusion

Secondary Outcome Measures

Outcome Measure
Time Frame
Predictive capabilities of Cardiac Index (measured by pulse contour)
Time Frame: within 30 minutes after start of infusion
within 30 minutes after start of infusion
Comparison of global enddiastolic volume index to baseline values
Time Frame: 30 minutes after start of infusion
30 minutes after start of infusion
Comparison of central venous pressure levels to baseline values
Time Frame: 30 minutes after start of infusion
30 minutes after start of infusion

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2010

Primary Completion (Anticipated)

December 1, 2010

Study Completion (Anticipated)

December 1, 2010

Study Registration Dates

First Submitted

October 21, 2010

First Submitted That Met QC Criteria

October 22, 2010

First Posted (Estimate)

October 25, 2010

Study Record Updates

Last Update Posted (Estimate)

October 25, 2010

Last Update Submitted That Met QC Criteria

October 22, 2010

Last Verified

October 1, 2010

More Information

Terms related to this study

Other Study ID Numbers

  • SMOOCH-1

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Prediction of Volume Responsiveness

Clinical Trials on PiCCO-parameter-guided volume challenge

Subscribe